HemoCue AB is recalling four boxes of HemoCue Glucose 201 Microcuvettes because they were exposed to transit times that exceeded established limits. These microcuvettes may not have been stored at recommended temperatures, which means their stability and accuracy over their entire lifetime can no longer be guaranteed. Using these microcuvettes could lead to incorrect or delayed blood glucose test results, which could impact medical treatment decisions. If you have affected products, you should stop using them and contact your distributor.
Improper storage conditions during shipment can degrade the chemical microcuvettes, leading to inaccurate glucose readings. This failure could result in incorrect medical diagnoses or delayed treatments for blood sugar issues.
Only 4 boxes within a specific McKesson Shipment are affected.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.